Literature DB >> 30853139

Genital infections due to the human papillomavirus.

Elena Sendagorta-Cudós1, Joaquín Burgos-Cibrián2, Manuel Rodríguez-Iglesias3.   

Abstract

The Human Papillomavirus (HPV) is a double-stranded DNA virus, with more than 200 different genotypes having been identified. This infection is considered the most common sexually transmitted infection (STI), and it is the cause of a significant number of diseases, both benign lesions (anogenital condylomas) and pre-malignant lesions and different cancers. The diagnosis of the infection is performed by molecular techniques based on the detection of viral DNA, the mRNA of oncogenic proteins and cellular alteration caused by the infection. Although there is no consensus regarding the best treatment, this should be individualised, and there are different options with ablative treatments being more effective but with greater recurrences, and immunomodulatory treatments being less effective in the short term but with fewer recurrences. Among the preventive strategies, vaccination against HPV is the best strategy against anogenital neoplasms and warts, its maximum effectiveness being when it is administered prior to exposure to HPV.
Copyright © 2019 Elsevier España, S.L.U. and Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica. All rights reserved.

Entities:  

Keywords:  Condiloma; Condyloma; Papillomavirus; Papilomavirus; Vaccines; Vacunas

Mesh:

Year:  2019        PMID: 30853139     DOI: 10.1016/j.eimc.2019.01.010

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin (Engl Ed)        ISSN: 2529-993X


  2 in total

1.  College males' behaviors, intentions, and influencing factors related to vaccinating against HPV.

Authors:  Alexis Koskan; Chad Stecher; Deborah Helitzer
Journal:  Hum Vaccin Immunother       Date:  2020-10-15       Impact factor: 3.452

2.  Oral, genital and anal human papillomavirus infections among female sex workers in Ibadan, Nigeria.

Authors:  Imran O Morhason-Bello; Kathy Baisley; Miquel A Pavon; Isaac F Adewole; Rasheed A Bakare; Silvia de Sanjosé; Suzanna C Francis; Deborah Watson-Jones
Journal:  PLoS One       Date:  2022-03-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.